Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
Authors:
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 3 (6) , 744-762
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- mTORC2 Activity Is Elevated in Gliomas and Promotes Growth and Cell Motility via Overexpression of RictorCancer Research, 2007
- The effects of hypoxia on the cells of the pulmonary vasculatureEuropean Respiratory Journal, 2007
- PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTORJournal of Clinical Investigation, 2007
- Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2Circulation Research, 2007
- Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1Developmental Cell, 2006
- Hypoxia-Induced Pulmonary Vascular RemodelingCirculation Research, 2006
- Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKBMolecular Cell, 2006
- Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage LineageThe American Journal of Pathology, 2006
- PTEN function: how normal cells control it and tumour cells lose itBiochemical Journal, 2004